The Michael J. Fox Foundation - Biomarkers to Support Therapeutic Trials Program | Research Funding

This program supports biomarkers research that will develop, optimize or analytically validate new or existing outcome measures to directly inform and transform therapeutic development.

The main focus of this RFA is on molecular bioassays which have the potential to directly serve clinical trials. Biomarker work as a tool to understand the role of a particular pathway in PD without a clear link to therapeutics will not be considered.

Funding: max. $300,000

Duration: 12-24 months

Eligibility: Applications may be submitted by researchers or clinicians in:

• U.S. and non-U.S. biotechnology/pharmaceutical companies, or other publicly or privately held for-profit entities; and
   
• U.S. and non-U.S. public and private non-profit entities, such as universities, colleges, hospitals, laboratories, units of state and local governments and eligible agencies of the federal government.
   
• Post-doctoral fellows are eligible to apply as co-investigators with the designation of an administrative primary investigator who directs the laboratory in which the fellow will conduct research.

• More information about the program is available here
• The application portal can be found here
• For any other questions, please contact the Research Office